| http://www.w3.org/ns/prov#value | - in a small subset of patients with relapsed or refractory DLBCL.???Enzastaurin is an investigational drug being studied in different types of cancer including brain, breast, colon, lung, ovarian and prostate.Study descriptionParticipants in the PRELUDE study will be divided into two groups in which they will receive either enzastaurin or a placebo every day for up to three years.
|
